Cyclacel Pharmaceuticals Stock Market Value
| CYCC Stock | USD 0.40 0.01 2.56% |
| Symbol | Cyclacel |
Cyclacel Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuticals. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.40) | Revenue Per Share 0.044 | Quarterly Revenue Growth (0.99) | Return On Assets (1.03) | Return On Equity (5.71) |
The market value of Cyclacel Pharmaceuticals is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclacel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cyclacel Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cyclacel Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cyclacel Pharmaceuticals.
| 11/11/2024 |
| 12/11/2024 |
If you would invest 0.00 in Cyclacel Pharmaceuticals on November 11, 2024 and sell it all today you would earn a total of 0.00 from holding Cyclacel Pharmaceuticals or generate 0.0% return on investment in Cyclacel Pharmaceuticals over 30 days. Cyclacel Pharmaceuticals is related to or competes with Eliem Therapeutics, Ikena Oncology, Ovid Therapeutics, Connect Biopharma, Edgewise Therapeutics, Rezolute, and XOMA. Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of canc... More
Cyclacel Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cyclacel Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cyclacel Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 48.1 | |||
| Value At Risk | (15.66) | |||
| Potential Upside | 12.87 |
Cyclacel Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cyclacel Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cyclacel Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Cyclacel Pharmaceuticals historical prices to predict the future Cyclacel Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.11) | |||
| Total Risk Alpha | (2.47) | |||
| Treynor Ratio | 1.85 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclacel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyclacel Pharmaceuticals Backtested Returns
Cyclacel Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of standard deviation over the last 3 months. Cyclacel Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cyclacel Pharmaceuticals' mean deviation of 5.65, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.64, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Cyclacel Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Cyclacel Pharmaceuticals is likely to outperform the market. At this point, Cyclacel Pharmaceuticals has a negative expected return of -1.17%. Please make sure to confirm Cyclacel Pharmaceuticals' potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if Cyclacel Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.38 |
Poor reverse predictability
Cyclacel Pharmaceuticals has poor reverse predictability. Overlapping area represents the amount of predictability between Cyclacel Pharmaceuticals time series from 11th of November 2024 to 26th of November 2024 and 26th of November 2024 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cyclacel Pharmaceuticals price movement. The serial correlation of -0.38 indicates that just about 38.0% of current Cyclacel Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.38 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cyclacel Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Cyclacel Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cyclacel Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Cyclacel Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Cyclacel Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cyclacel Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cyclacel Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cyclacel Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cyclacel Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Cyclacel Pharmaceuticals Lagged Returns
When evaluating Cyclacel Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cyclacel Pharmaceuticals stock have on its future price. Cyclacel Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cyclacel Pharmaceuticals autocorrelation shows the relationship between Cyclacel Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Cyclacel Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cyclacel Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cyclacel Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cyclacel Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cyclacel Pharmaceuticals Stock:Check out Cyclacel Pharmaceuticals Correlation, Cyclacel Pharmaceuticals Volatility and Cyclacel Pharmaceuticals Alpha and Beta module to complement your research on Cyclacel Pharmaceuticals. For information on how to trade Cyclacel Stock refer to our How to Trade Cyclacel Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Cyclacel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.